2,344 followers
Ph 1 study evaluating combo of an AKT inhibitor (MK-2206) + trastuzumab in pats w/ HER2+ solid tumors http://t.co/xwABWd1rUs
Ph 1 study evaluating combo of an AKT inhibitor (MK-2206) + trastuzumab in pats w/ HER2+ solid tumors http://t.co/xwABWd1rUs
Breast Cancer Research | Abstract | A phase 1 study evaluating the combination of an allosteric AKT inhibitor... http://t.co/mCaOzTQKBD
Ph 1 study evaluating combo of an AKT inhibitor (MK-2206) + trastuzumab in pats w/ HER2+ solid tumors http://t.co/xwABWd1rUs
Ph 1 study evaluating combo of an AKT inhibitor (MK-2206) + trastuzumab in pats w/ HER2+ solid tumors http://t.co/xwABWd1rUs